v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 21,406 $ 15,485
Marketable securities 46,093 27,005
Prepaid expenses and other current assets 8,533 4,165
Total current assets 76,032 46,655
Long-term marketable securities 7,161  
Property and equipment, net 827 910
Operating lease right-of-use assets 2,682 2,811
Other assets 105 740
Total assets 86,807 51,116
Current liabilities:    
Accounts payable 3,055 1,806
Accrued liabilities 4,254 3,610
Current portion of lease liabilities 651 644
Total current liabilities 7,960 6,060
Warrant liabilities 18,552 29,404
Long-term portion of lease liabilities 2,788 2,959
Other liabilities 73 73
Total liabilities 29,373 38,496
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized and none outstanding at June 30, 2021 and December 31, 2020
Common stock, $0.0001 par value, 125,000,000 shares authorized, 39,332,721 shares and 27,810,161 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 4 3
Additional paid-in capital 308,333 252,908
Accumulated other comprehensive loss (42) (21)
Accumulated deficit (250,861) (240,270)
Total stockholders' equity 57,434 12,620
Total liabilities and stockholders' equity $ 86,807 $ 51,116

Source

v3.21.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses        
Research and development $ 7,777 $ 5,544 $ 15,798 $ 10,648
General and administrative 2,935 2,619 5,700 5,579
Total operating expenses 10,712 8,163 21,498 16,227
Loss from operations (10,712) (8,163) (21,498) (16,227)
Other income (expense):        
Interest income 30 26 55 95
Other expense 0 (2,175) 0 (2,175)
Change in fair value of warrant liabilities 5,286 (7,305) 10,852 (6,889)
Total other income (expense), net 5,316 (9,454) 10,907 (8,969)
Net loss $ (5,396) $ (17,617) $ (10,591) $ (25,196)
Basic and diluted net loss per share $ (0.14) $ (0.88) $ (0.31) $ (1.43)
Shares used in computing net loss per share 39,332,721 19,991,894 34,176,801 17,661,968

Source

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (10,591) $ (25,196)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 73 85
Stock-based compensation expense 1,519 1,285
Change in fair value of warrant liabilities (10,852) 6,889
Issuance costs allocated to warrants   2,175
Net amortization of premium on marketable securities 212 8
Changes in operating assets and liabilities:    
(Increase) decrease in prepaid expenses and other current and non-current assets (3,759) 1,230
Increase (decrease) in accounts payable, accrued liabilities and other liabilities 1,894 (4,170)
Net cash used in operating activities (21,504) (17,694)
Cash flows from investing activities    
Purchases of marketable securities (44,822) (37,515)
Proceeds from sales and maturities of marketable securities 18,340 9,981
Net cash used in investing activities (26,482) (27,534)
Cash flows from financing activities    
Proceeds from issuance of securities 57,500 55,500
Payment of financing costs of securities sold (3,703) (3,637)
Proceeds from the exercise of warrants 110  
Net cash provided by financing activities 53,907 51,863
Net increase in cash and cash equivalents 5,921 6,635
Cash and cash equivalents at beginning of period 15,485 24,184
Cash and cash equivalents at end of period $ 21,406 30,819
Supplemental disclosures of cash flow information:    
Issuance of warrants to purchase common stock   $ 31,391

Source